ACM Pivotal Global Central Laboratory

ACM Global Laboratories is a leading global central laboratory service provider that supports clinical trials for pharmaceutical, biotech, and medical device companies. In early 2024, the company was acquired by Pivotal, a prominent European Contract Research Organization (CRO), to create a fully integrated suite of clinical research and diagnostic services. ACM offers a comprehensive range of testing services, including safety and specialty testing, pathology, microbiology, and flow cytometry, across all phases of clinical development. The company operates a global network of laboratories with facilities in the United States, United Kingdom, India, Singapore, and China, ensuring standardized data and logistics management. Their expertise covers a wide array of therapeutic areas, with specialized focus on oncology, infectious diseases, and metabolic disorders.